ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P83
Within normal range
vs 2Y Ago
0.5x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 22.05% |
| Q3 2025 | -11.72% |
| Q2 2025 | -28.07% |
| Q1 2025 | -178.77% |
| Q4 2024 | 317.02% |
| Q3 2024 | -41.77% |
| Q2 2024 | -16.28% |
| Q1 2024 | -29.00% |
| Q4 2023 | 43.12% |
| Q3 2023 | 12.74% |
| Q2 2023 | -10.10% |
| Q1 2023 | -21.17% |
| Q4 2022 | -132.93% |
| Q3 2022 | -4.51% |
| Q2 2022 | 10.64% |
| Q1 2022 | -43.10% |
| Q4 2021 | 11.66% |
| Q3 2021 | -26.53% |
| Q2 2021 | 0.00% |
| Q1 2021 | 66.12% |
| Q4 2020 | 0.00% |
| Q2 2020 | -23.29% |
| Q1 2020 | 24.37% |
| Q4 2019 | 0.00% |